(Q36495555)

14 August 2017

1 reference

title

Impact of age, race, and obesity on hypertensive mechanisms and therapy (English)

1 reference

14 August 2017

0 references

M. R. Weir

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674840

26 October 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

14 August 2017

17 May 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1674840

full work available at URL

26 October 2022

https://api.elsevier.com/content/article/PII:000293439190479H?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

https://api.elsevier.com/content/article/PII:000293439190479H?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

American Journal of Medicine

26 October 2022

published in

1 reference

14 August 2017

volume

90

1 reference

14 August 2017

issue

5A

1 reference

14 August 2017

page(s)

3S-14S

1 reference

Cellular mechanisms of vascular growth

14 August 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Pressure-independent increases in vascular resistance in hypertension: role of sympathoadrenergic influences.

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Functional and structural changes in the rabbit ear artery after sympathetic denervation

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

The Sodium-Potassium Pump in Volume Expanded Hypertension

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Correlations and otherwise between blood pressure, cardiac mass and resistance vessel characteristics in hypertensive, normotensive and hypertensive/normotensive hybrid rats.

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Significance of the vascular renin-angiotensin pathway

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Clinical pharmacology of selective alpha blockers. Hemodynamics and effects on lipid levels

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Effects of clonidine on central and peripheral nerve tone in primary hypertension

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Calcium, vascular smooth muscle, and calcium entry blockers in hypertension

26 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

The role of calcium channel blockers in the treatment of hypertension

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension

26 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Changes of cardiac output in hypertensive disease

26 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Individualization of antihypertensive therapy: an approach based on hemodynamics and age.

26 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Relationship Between Cardiac Output and Peripheral Resistance in Borderline Hypertension

26 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Hemodynamics of hypertension

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study

26 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Recruitment of elderly volunteers for a multicenter clinical trial: the SHEP pilot study

26 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Isolated systolic hypertension in 14 communities

26 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial

26 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Sympathetic-adrenal medullary and cardiovascular responses to acute cold stress in adult and aged rats

26 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

26 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages

26 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Effects of age on renal sodium homeostasis and its relevance to sodium sensitivity

26 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

26 October 2022

Hypertension in the aged

49

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Effect of advancing age on cardiopulmonary baroreceptor function in hypertensive men.

26 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Physiologic considerations in left ventricular hypertrophy

26 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Clinical and Hemodynamic Determinants of Left Ventricular Dimensions

26 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy

26 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy

26 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Prevalence and natural history of electrocardiographic left ventricular hypertrophy

26 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects

26 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

26 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Perspectives on systolic hypertension. The Framingham study.

26 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Stepped care and profiled care in the treatment of hypertension: considerations for black Americans

26 October 2022

66

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Role of blood pressure in cardiovascular morbidity and mortality

26 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Hypertension Is Different in Blacks

26 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Racial differences in the incidence of treatment for end-stage renal disease

26 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Racial differences in blood pressure control

26 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Physiologic and hemodynamic considerations in blood pressure control while maintaining organ perfusion

26 October 2022

75

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Letter: Racial disparity of plasma volume in hypertensive man

26 October 2022

76

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Racial differences in pressure, volume and renin interrelationships in essential hypertension

26 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Racial differences in cardiac adaptation to essential hypertension determined by echocardiography indexes

26 October 2022

78

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Disparate cardiovascular effects of obesity and arterial hypertension

26 October 2022

80

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Role of the sympathetic nervous system in blood pressure maintenance in obesity

26 October 2022

82

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Cardiovascular effects of verapamil in patients with essential hypertension

26 October 2022

84

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Renal effects of diltiazem in primary hypertension.

26 October 2022

85

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.

26 October 2022

86

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus

26 October 2022

89

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Antihypertensive and renal effects of orally administered verapamil

26 October 2022

91

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Nifedipine in the treatment of hypertension in the elderly

26 October 2022

94

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Antihypertensive and metabolic effects of long-term therapy with nifedipine slow-release tablets

26 October 2022

95

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

A comparison of verapamil and propranolol for the initial treatment of hypertension. Racial differences in response

26 October 2022

97

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension

26 October 2022

98

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.

26 October 2022

99

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension

26 October 2022

100

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonists.

26 October 2022

104

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

The efficacy and safety of long-term antihypertensive therapy with nifedipine

26 October 2022

105

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial

26 October 2022

106

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.

26 October 2022

107

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Acute and chronic studies of diltiazem in elderly versus young hypertensive patients

26 October 2022

108

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

26 October 2022

109

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Implications of local angiotensin production in cardiovascular physiology and pharmacology

26 October 2022

112

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Evolution of the clinical management of hypertension. Emerging role of "specific" vasodilators as initial therapy.

26 October 2022

114

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension

26 October 2022

115

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

The effects of enalapril on blood pressure, renal hemodynamics, and renal function

26 October 2022

116

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Enalapril Worldwide Experience

26 October 2022

117

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension

26 October 2022

118

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Low-dose captopril for the treatment of mild to moderate hypertension

26 October 2022

119

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Responses to captopril and hydrochlorothiazide in black patients with hypertension

26 October 2022

120

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients

26 October 2022

121

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

The effects of antihypertensive therapy on the quality of life

26 October 2022

122

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

[Regression of myocardial hypertrophy in hypertensives on chronic beta-receptor block]

26 October 2022

123

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

26 October 2022

124

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

26 October 2022

125

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

26 October 2022

126

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

Pharmacologic management of systemic hypertension in blacks

26 October 2022

127

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90479-H

26 October 2022

Identifiers

1 reference

14 August 2017

1 reference